CoChat

Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation

Open access
Jo, Myungjin, Kim, Jong-Heon, Song, Gyun Jee, Seo, Minchul, Hwang, Eun Mi, Suk, Kyoungho · 2017 · The Journal of Neuroscience
Cited by 180

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Orosomucoid (ORM) is an acute-phase protein that belongs to the immunocalin subfamily, a group of small-molecule-binding proteins with immunomodulatory functions. Little is known about the role of ORM proteins in the CNS. The aim of the present study was to investigate the brain expression of ORM and its role in neuroinflammation. Expression of Orm2, but not Orm1 or Orm3, was highly induced in the mouse brain after systemic injection of lipopolysaccharide (LPS). Plasma levels of ORM2 were also significantly higher in patients with cognitive impairment than in normal subjects. RT-PCR, Western blot, and immunofluorescence analyses revealed that astrocytes are the major cellular sources of ORM2 in the inflamed mouse brain. Recombinant ORM2 protein treatment decreased microglial production of proinflammatory mediators and reduced microglia-mediated neurotoxicity in vitro. LPS-induced microglial activation, proinflammatory cytokines in hippocampus, and neuroinflammation-associated cognitive deficits also decreased as a result of intracerebroventricular injection of recombinant ORM2 protein in vivo. Moreover, lentiviral shRNA-mediated Orm2 knockdown enhanced LPS-induced proinflammatory cytokine gene expression and microglial activation in the hippocampus. Mechanistically, ORM2 inhibited C-C chemokine ligand 4 (CCL4)-induced microglial migration and activation by blocking the interaction of CCL4 with C-C chemokine receptor type 5. Together, the results from our cultured glial cells, mouse neuroinflammation model, and patient studies suggest that ORM2 is a novel mediator of astrocyte–microglial interaction. We also report that ORM2 exerts anti-inflammatory effects by modulating microglial activation and migration during brain inflammation. ORM2 can be exploited therapeutically for the treatment of neuroinflammatory diseases. SIGNIFICANCE STATEMENT Neural cell interactions are important for brain physiology and pathology. Particularly, the interaction between non-neuronal cells plays a central role in regulating brain inflammation, which is closely linked to many brain disorders. Here, we newly identified orosomucoid-2 (ORM2) as an endogenous protein that mediates such non-neuronal glial cell interactions. Based on the critical role of astrocyte-derived ORM2 in modulating microglia-mediated neuroinflammation, ORM2 can be exploited for the diagnosis, prevention, or treatment of devastating brain disorders that have a strong neuroinflammatory component, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.2534-16.2017

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 53

  1. 10.1042/bj3560121 · doi:10.1042/bj3560121
  2. 10.1186/1471-2377-5-22 · DOI
  3. 10.1007/BF00494364 · doi:10.1007/bf00494364
  4. 10.1007/BF00915815 · doi:10.1007/bf00915815
  5. 10.1038/npp.2014.199 · DOI
  6. 10.1189/jlb.0908551 · DOI
  7. 10.1016/j.jns.2011.03.023 · DOI
  8. 10.1096/fj.07-9411com · DOI · Paper page
  9. 10.3390/brainsci3031109 · DOI · Paper page
  10. Costello, 1984, Inhibition of neutrophil activation by alpha1-acid glycoprotein, Clin Exp Immunol, 55, 465
  11. Daveau, 1994, IL-6-induced changes in synthesis of alpha 1-acid glycoprotein in human hepatoma Hep3B cells are distinctively regulated by monoclonal antibodies directed against different epitopes of IL-6 receptor (gp80), Eur Cytokine Netw, 5, 601
  12. 10.2174/092986707780597961 · DOI · Paper page
  13. 10.1001/archneur.1976.00500100002003 · DOI
  14. Elg, 1997, Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma, Cancer, 80, 1448, 10.1002/(SICI)1097-0142(19971015)80:8<1448::AID-CNCR12>3.0.CO;2-5 · doi:10.1002/(sici)1097-0142(19971015)80:8<1448::aid-cncr12>3.0.co;2-5
  15. 10.1016/S0167-4838(00)00153-9 · DOI · Paper page
  16. Frautschy, 1998, Microglial response to amyloid plaques in APPsw transgenic mice, Am J Pathol, 152, 307
  17. 10.1002/glia.20543 · DOI · Paper page
  18. 10.1046/j.1471-4159.2003.01609.x · DOI
  19. 10.1016/j.bbagen.2005.03.012 · DOI
  20. 10.1155/2012/475153 · DOI
  21. 10.1016/j.brainresbull.2016.03.017 · DOI
  22. 10.1186/1742-2094-9-149 · DOI · Paper page
  23. 10.1186/1742-2094-9-207 · DOI · Paper page
  24. Kremer, 1988, Drug binding to human alpha-1-acid glycoprotein in health and disease, Pharmacol Rev, 40, 1, 10.1016/S0031-6997(25)00015-8 · DOI · Paper page
  25. 10.1007/BF00914025 · DOI
  26. 10.1523/JNEUROSCI.5273-08.2009 · DOI · Paper page
  27. 10.1074/jbc.M111.299248 · DOI · Paper page
  28. 10.1002/jnr.22779 · DOI · Paper page
  29. 10.1074/jbc.M111.330662 · DOI · Paper page
  30. 10.1074/jbc.M109.085464 · DOI · Paper page
  31. 10.1523/JNEUROSCI.2117-15.2016 · DOI · Paper page
  32. 10.1084/jem.180.4.1571 · DOI
  33. 10.1016/S0167-4838(00)00164-3 · DOI · Paper page
  34. 10.1136/jnnp.48.8.835 · doi:10.1136/jnnp.48.8.835
  35. 10.1083/jcb.85.3.890 · DOI · Paper page
  36. McManus, 1998, Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia, J Immunol, 160, 1449, 10.4049/jimmunol.160.3.1449 · DOI · Paper page
  37. 10.1523/JNEUROSCI.3696-05.2006 · DOI · Paper page
  38. 10.1023/A:1027342909423 · DOI
  39. 10.1097/00024382-200116030-00001 · DOI · Paper page
  40. 10.1111/j.1476-5381.2010.00659.x · DOI · Paper page
  41. 10.1002/eji.201242836 · DOI · Paper page
  42. 10.1007/BF00917452 · doi:10.1007/bf00917452
  43. 10.1016/S0166-2236(97)01139-9 · DOI · Paper page
  44. 10.1096/fj.01-0514fje · DOI · Paper page
  45. 10.1016/j.jchemneu.2005.07.003 · DOI · Paper page
  46. 10.1523/JNEUROSCI.1717-08.2008 · DOI · Paper page
  47. 10.1016/S0301-0082(98)00083-5 · DOI · Paper page
  48. 10.1007/s00401-006-0083-7 · DOI · Paper page
  49. 10.1038/200266a0 · DOI
  50. 10.1016/B978-0-12-398314-5.00004-0 · DOI · Paper page
  51. 10.4049/jimmunol.166.10.6383 · DOI · Paper page
  52. 10.1016/j.jneuroim.2006.11.014 · DOI · Paper page
  53. 10.1016/j.mvr.2012.05.003 · DOI

Cited by

See all 180

Metadata

Authors
Jo, M., Kim, J.-H., Song, G. J., Seo, M., Hwang, E. M., & Suk, K.
Venue
The Journal of Neuroscience
Published
2017-02-13
Volume
37
Issue
11
Pages
2878-2894
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2588926033
Cited by
180
References
17
FWCI
4.25
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation. https://app.cochat.ai/papers/10.1523/jneurosci.2534-16.2017
The paper
Jo, M., Kim, J.-H., Song, G. J., Seo, M., Hwang, E. M., & Suk, K. (2017). Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.2534-16.2017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.